The studies show that premenopausal women detected cuteness better than same aged postmenopausal women. FSH may contribute to postmenopausal osteoporosis and cardiovascular disease. Raloxifene also decreases prolactin levels in postmenopausal women. Raloxifene is used for the treatment and prevention of osteoporosis in postmenopausal women. Tamoxifen treatment of postmenopausal women is associated with beneficial effects on serum lipid profiles. Fluoride supplementation has been extensively studied for the treatment of postmenopausal osteoporosis. Raloxifene is used to reduce the risk of breast cancer in postmenopausal women. Hormonal vaginitis includes atrophic vaginitis usually found in postmenopausal women. This form of endometrial cancer is more common in postmenopausal women. Bazedoxifene is used in the treatment of postmenopausal osteoporosis. Early studies mentioned prevalence in obese postmenopausal women. Raloxifene has been studied as an adjunct in the treatment of schizophrenia in postmenopausal women. Bazedoxifene is also used in the prevention of postmenopausal osteoporosis. The American endocrinologist Fuller Albright linked osteoporosis with the postmenopausal state. Progesterone levels are low in children and postmenopausal women.